Zhang et al. demonstrated that an IL-18-neutralizing antibody could impede the Th17 immune response in a psoriasis-like mouse model, indicating that the IL-18-mediated T cell response plays a crucial role in the pathogenesis of psoriasis and that inhibiting IL-18 could be a promising therapeutic strategy [49,155]. The gene discussed is IL18; the disease is psoriasis.